Advances in Biomarkers (Technical Insights)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service outlines the key global developments in the field of biomarkers.

Table of Contents

Advances in Biomarkers (Technical Insights), Executive SummaryScope and MethodologyScope and Segmentation of the Research ServiceResearch MethodologyOverview of BiomarkersIntroduction to BiomarkersApplications of BiomarkersTechnology Platform for Biomarker DiscoveryAdvances in Biomarkers (Technical Insights), Assessment of Enabling Technologies for Biomarker DetectionNoteworthy Innovations in Companies and UniversitiesMASStermind Approach for Biomarker Discovery and ValidationReverse-Capture Autoantibody Microarray Platform for Profiling Prostate Cancer BiomarkersDifferential Methylation Hybridization Platform for Drug Response PredictionProtein Detection Made Easy with a New Microchip SystemSoftware Solution for Analysis of Microarray Expression and ArrayCGH ExperimentsResearch Grade Mass Spectrometer for Biomarker RecognitionMicrofluidics-On-Chip Synthesis Platform for Biomarker DiscoveryBioinformatics Solution for 2D Image AnalysisIsobaric Mass Tags To Heighten MS PerformanceBioinformatics Database as a Repository of BiomarkersImaging Science and Biomarker Development at ISBECompetitive Template PCR with a TwistChip-Based Technology for Detecting BiomarkersPeptidomics In Biomarker DiscoveryDrivers and ChallengesDriversChallengesAdvances in Biomarkers (Technical Insights), Assessment of Biomarker ApplicationsNoteworthy Innovations in Companies and UniversitiesBiomarker-Based Test for Detection of Tuberculosis--AustraliaProteomics Technology Platform for Target Identification and Predictive MedicineIdentification of Plasma Biomarkers for Statin-Induced MyopathyWater Diffusion-Based Biomarker for Breast CancerNon-Invasive Method to Assess Human Embryo Viability Using Metabolomic ProfilingProtein Biomarkers Detected for Ischaemic Liver InjuryDNA Methylation Technology for Diagnostic and Prognostic TestsSmartAssays for Early Detection of Damage to Kidney Liver or PancreasCLIA-Approved Test to Predict Breast Cancer RecurrenceBiomarker Development for Traumatic Brain Injury Power3’s Foray into Biomarker Discovery and DevelopmentFDA-Approved Prognostic Test For Breast CancerBiomarker to Detect Cardiovascular Disease at an Early StageDrivers And ChallengesDriversChallengesAdvances in Biomarkers (Technical Insights), Technology Adoption Factor AnalysisCompetitive LandscapeKey Findings in the Biomarker IndustryGeographic Trend AnalysisIndustry InsightsBiomarker Analysis by Therapeutic AreasAnalysis of Biomarkers in Clinical TrialsSWOT AnalysisAdvances in Biomarkers (Technical Insights), Patents and Database of Key Industry ParticipantsPatentsIndustry PatentsAcademic PatentsKey ParticipantsCompaniesUniversitiesAdvances in Biomarkers (Technical Insights), Decision Support DatabaseDatabase TablesGlobal R&D Expenditure for Biotechnology (2002-2012)Percent Government R&D Investment in Biotechnology (2002-2012)Global Pharmaceutical R&D Expenditure (2002-2012)Global Percentage Pharmaceutical R&D Expenditure (2002-2012)




Related Research

Release Date : 08-Sep-17

Region : Global

Release Date : 08-Sep-17

Region : Global

Release Date : 01-Sep-17

Region : Global

Release Date : 25-Aug-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.